The most used methods for
isoflavone determination are liquid-liquid (LLE) and solid-phase extraction (SPE) [14].
For 12 weeks in a randomized trial, 70 women aged 18 to 40 years with polycystic ovary syndrome were assigned to consume 50 mg per day of a soy
isoflavone supplement or a placebo.
Because equol is believed to elicit greater biological reaction than other
isoflavone metabolites, it was anticipated that the clinical effectiveness of the ISP containing soy
isoflavones was dependent on eqoul.
Compared with the placebo group, soy
isoflavone administration significantly decreased circulating levels of insulin and other biological markers associated with insulin resistance - a condition whereby the body's tissues are resistant to the effects of insulin, which can lead to type 2 diabetes.
Isoflavone is one of the phytoestrogens with similar molecular structures to animal estrogen and has weak estrogenic effects.
The 66mg of
isoflavone that we use in this study is equivalent to eating an oriental diet, which is rich in soy foods."
Intergroup comparison revealed that decrease in the mean total AV lesion count before and after treatment was significant in
isoflavone 160 mg group (pless than 0.05 ), while in the placebo, 40 mg, 80 mg, 120 mg groups it was insignificant (pgreater than 0.05 ).
The cultured cells were divided into six groups: control (vehicle), [MPP.sup.+] (250 [micro]mol/L) only,
isoflavone (10 [micro]M) + [MPP.sup.+] (250 [micro]mol/L) group,
isoflavone (10 [micro]M) only group, Z-YVAD-CHO (10 mM) + [MPP.sup.+] group, and Z-DEVD-CHO (10 mM) + [MPP.sup.+] group.
Methods: In this study, mice were divided into 4 groups (15 mice per group) of control, the dietary Soy
Isoflavone Extract (SIE, 100 mg/hg diet), the Docetaxel (DOCE, 10 mg/kg) injection and the combination of dietary soy
isoflavone extract and intravenous docetaxel injection (DOCE+SIE).
"It behooves us to examine the safety-related outcomes and rates of any adverse events in women consuming over-the-counter soy
isoflavone supplements, which could be 100 mg of
isoflavones a day or more," Dr.
Another alarm over soy and the breast: in 1998, researchers reported that genistein, a major soy
isoflavone, stimulated the growth of estrogen receptorpositive (ER+) breast tumors in a special strain of mice.
Concerns have been raised because of soy's
isoflavone content which could interfere with tamoxifen, a drug commonly used to treat breast cancer, and because of the potential for
isoflavones to stimulate cell growth.